These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 36627683)

  • 1. The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics.
    Wu W; Cheng Y; Zhou H; Sun C; Zhang S
    Virol J; 2023 Jan; 20(1):6. PubMed ID: 36627683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design.
    Maghsood F; Ghorbani A; Yadegari H; Golsaz-Shirazi F; Amiri MM; Shokri F
    Rev Med Virol; 2023 May; 33(3):e2431. PubMed ID: 36790816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
    J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein.
    Huang Y; Huang C; Chen J; Chen S; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
    Microbiol Spectr; 2024 Apr; 12(4):e0341023. PubMed ID: 38376366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of the N-terminal intrinsically disordered region of the severe acute respiratory syndrome coronavirus 2 nucleocapsid protein to RNA-induced phase separation.
    Zachrdla M; Savastano A; Ibáñez de Opakua A; Cima-Omori MS; Zweckstetter M
    Protein Sci; 2022 Sep; 31(9):e4409. PubMed ID: 36040256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.
    Zhao M; Yu Y; Sun LM; Xing JQ; Li T; Zhu Y; Wang M; Yu Y; Xue W; Xia T; Cai H; Han QY; Yin X; Li WH; Li AL; Cui J; Yuan Z; Zhang R; Zhou T; Zhang XM; Li T
    Nat Commun; 2021 Apr; 12(1):2114. PubMed ID: 33837182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine.
    Feng W; Xiang Y; Wu L; Chen Z; Li Q; Chen J; Guo Y; Xia D; Chen N; Zhang L; Zhu S; Zhao KN
    J Clin Lab Anal; 2022 Jun; 36(6):e24479. PubMed ID: 35527696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.
    Chau BA; Chen V; Cochrane AW; Parent LJ; Mouland AJ
    Cell Rep; 2023 Jan; 42(1):111968. PubMed ID: 36640305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.
    Fernandes Q; Inchakalody VP; Merhi M; Mestiri S; Taib N; Moustafa Abo El-Ella D; Bedhiafi T; Raza A; Al-Zaidan L; Mohsen MO; Yousuf Al-Nesf MA; Hssain AA; Yassine HM; Bachmann MF; Uddin S; Dermime S
    Ann Med; 2022 Dec; 54(1):524-540. PubMed ID: 35132910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.
    Bai Z; Cao Y; Liu W; Li J
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS-CoV-2 nucleocapsid protein and its liquid-liquid phase separation.
    Eltayeb A; Al-Sarraj F; Alharbi M; Albiheyri R; Mattar EH; Abu Zeid IM; Bouback TA; Bamagoos A; Uversky VN; Rubio-Casillas A; Redwan EM
    J Cell Biochem; 2024 Mar; 125(3):e30530. PubMed ID: 38349116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic sequence, origin, and diagnosis of SARS-CoV-2.
    Wang H; Li X; Li T; Zhang S; Wang L; Wu X; Liu J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1629-1635. PubMed ID: 32333222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2.
    Dangi T; Class J; Palacio N; Richner JM; Penaloza MacMaster P
    Cell Rep; 2021 Sep; 36(10):109664. PubMed ID: 34450033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) achieve immune evasion?: A narrative review.
    Bai Y; Ning K
    Medicine (Baltimore); 2024 Apr; 103(16):e37780. PubMed ID: 38640329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
    Li L; Zhu C; Zhao X; Qu F
    Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development.
    Yu H; Guan F; Miller H; Lei J; Liu C
    Emerg Microbes Infect; 2023 Dec; 12(1):e2164219. PubMed ID: 36583642
    [No Abstract]   [Full Text] [Related]  

  • 19. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides.
    Maus A; Renuse S; Kemp J; Madugundu AK; Vanderboom PM; Blommel J; Jerde C; Dasari S; Kipp BR; Singh RJ; Grebe SK; Pandey A
    J Proteome Res; 2022 Jan; 21(1):142-150. PubMed ID: 34779632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.